BackImmunovant Overview
Immunovant Inc

Immunovant Discounted Cash Flow

DCF Analysis for IMVT.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$4.94

Current Fair Value

$4.94
↓ 85.2% Downside

Overvalued by 85.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading